T 1894/17 (Rivastigmine TTS / NOVARTIS) of 19.10.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T189417.20211019
- Date of decision
- 19 October 2021
- Case number
- T 1894/17
- Petition for review of
- -
- Application number
- 14163637.3
- IPC class
- A61K 9/70A61K 31/27
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Transdermal therapeutic system comprising rivastigmine
- Applicant name
- Novartis AG
Novartis Pharma GmbH
LTS LOHMANN Therapie-Systeme AG - Opponent name
- -
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 76(1)
- Keywords
- Divisional application - added subject-matter (yes)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.